COVID-19 and beyond : oversight of the FDA's foreign drug manufacturing inspection process : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, second session, June 2, 2020.

Bibliographic Details
Corporate Author: United States. Congress. Senate. Committee on Finance (Author)
Format: Government Document eBook
Language:English
Published: Washington : U.S. Government Publishing Office, 2021.
Series:S. hrg. ; 116-490
Subjects:
Online Access:https://purl.fdlp.gov/GPO/gpo161153

Similar Items